Related Experiment Video
Updated: Feb 17, 2026

Porphyromonas gingivalis as a Model Organism for Assessing Interaction of Anaerobic Bacteria with Host Cells
Published on: December 17, 2015
Proteobacteria: A Common Factor in Human Diseases
G Rizzatti1, L R Lopetuso1, G Gibiino1
1Department of Internal Medicine, Gastroenterology Division, Policlinico "A. Gemelli" Hospital, Rome, Italy.
Abstract:
Microbiota represents the entire microbial community present in the gut host. It serves several functions establishing a mutualistic relation with the host. Latest years have seen a burst in the number of studies focusing on this topic, in particular on intestinal diseases. In this scenario, Proteobacteria are one of the most abundant phyla, comprising several known human pathogens. This review highlights the latest findings on the role of Proteobacteria not only in intestinal but also in extraintestinal diseases. Indeed, an increasing amount of data identifies Proteobacteria as a possible microbial signature of disease. Several studies demonstrate an increased abundance of members belonging to this phylum in such conditions. Major evidences currently involve metabolic disorders and inflammatory bowel disease. However, more recent studies suggest a role also in lung diseases, such as asthma and chronic obstructive pulmonary disease, but evidences are still scant. Notably, all these conditions are sustained by various degree of inflammation, which thus represents a core aspect of Proteobacteria-related diseases.
Insights
Proteobacteria, a gut bacteria group, are increasingly linked to various diseases, both in the gut and elsewhere. Their elevated presence may signal conditions like inflammatory bowel disease and metabolic disorders.
Area of Science:
- Microbiology
- Human Health
- Gut Microbiome Research
Background:
- The gut microbiota plays a crucial role in host health through mutualistic interactions.
- Proteobacteria are a dominant phylum within the gut microbiota, including known human pathogens.
- Recent research has intensified focus on the gut microbiota's role in intestinal diseases.
Purpose of the Study:
- To review current findings on the involvement of Proteobacteria in intestinal and extraintestinal diseases.
- To highlight Proteobacteria as a potential microbial signature for various pathological conditions.
- To explore the link between Proteobacteria and inflammation-associated diseases.
Main Methods:
- Literature review of recent studies on Proteobacteria and disease.
- Analysis of data on the abundance of Proteobacteria in different disease states.
- Synthesis of evidence linking Proteobacteria to metabolic, inflammatory, and lung diseases.
Main Results:
- An increased abundance of Proteobacteria is observed in several disease conditions.
- Strong evidence links Proteobacteria to metabolic disorders and inflammatory bowel disease.
- Emerging, though limited, evidence suggests a role in lung diseases like asthma and COPD.
Conclusions:
- Proteobacteria are increasingly recognized as significant players in both intestinal and extraintestinal diseases.
- Elevated Proteobacteria levels may serve as a microbial biomarker for disease.
- Inflammation is a common underlying factor in diseases associated with Proteobacteria.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:24Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
Published on: July 4, 2018
Related Concept Videos
Bacterial Phylum Proteobacteria
Bacterial Phylum Actinobacteria
Bacterial Phylum Bacteroidota
Bacterial Phylum Spirochaetes
Bacterial Phylum Firmicutes
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...